Results 81 to 90 of about 63,906 (257)

Aminoglikozid és karbapenem rezisztencia gének megoszlásának vizsgálata Debreceni Egyetem Klinikáiról származó Acinetobacter baumannii izolátumok körében [PDF]

open access: yes, 2017
A dolgozat a növekvő antibiotikum rezisztenciával foglalkozik az Acinetobacter baumannii karbapenem és aminoglikozid rezisztencia génjeinek vizsgálatával.
Nádasdi, Dávid Tamás
core  

Genome sequence of vB_AbaS_TRS1, a viable prophage isolated from Acinetobacter baumannii strain A118 [PDF]

open access: yes, 2016
© 2016 Turner et al. A novel temperate phage, vB_AbaS_TRS1, was isolated from cultures of Acinetobacter baumannii strain A118 that had been exposed to mitomycin C.
Sutton, J. Mark   +5 more
core   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Biofilm formation and biocide resistance of acinetobacter baumannii [PDF]

open access: yes
Multi drug resistant (MDR) strains of Acinetobacter baumannii have emerged as a major cause of nosocomial infections associated with significant morbidity and mortality.
Shoukat, Kamran
core  

Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex [PDF]

open access: yes, 2017
Background: The emergence of carbapenem-resistant Acinetobacter baumannii (CRAB) complex has posed a great challenge to clinicians worldwide. Sitafloxacin has been shown to have in vitro activity against pathogens resistant to other fluoroquinolones ...
Huang, Yu-Shan;Wang, Jann-Tay;Sheng, Wang-Huei;Chuang, Yu-Chung;Chang, Shan-Chwen   +1 more
core   +1 more source

Unlocking the Multifunctional Properties of Litsea cubeba Essential Oil: Composition, Antimicrobial, Antibiofilm and Insecticidal Activities

open access: yesFlavour and Fragrance Journal, EarlyView.
Unveiling the chemical and biological properties of Litsea cubeba essential oil. ABSTRACT Litsea cubeba essential oil (LCEO) is recognised for its broad spectrum of biological activities, including antimicrobial and insecticidal effects, making it a promising natural alternative to synthetic agents.
Miroslava Kačániová   +10 more
wiley   +1 more source

Acinetobacter Baumannii and Acinetobacter Genospecies 13tu and 3 Bacteraemia: Comparison of Clinical Features, Prognostic Factors and Outcomes [PDF]

open access: yes, 2012
Objectives: To investigate the clinical impact of different genospecies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex (ACB complex; A. baumannii, Acinetobacter gen. sp. 13TU and Acinetobacter gen. sp.
LEE, YI-CHIEH;HUANG, YU-TSUNG;TAN, CHE-KIM;KUO, YAO-WEN;LIAO, CHUN-HSIN;LEE, PING-ING;HSUEH, PO-REN   +1 more
core   +1 more source

Molecular Characterization of Multiple Antibiotic-Resistant Acinetobacter baumannii Isolated from Egyptian Patients [PDF]

open access: yes, 2020
Acinetobacter baumannii is an opportunistic microorganism commonly found in intensive care units (ICUs), and it is responsible for a broad span of hospital-acquired infections.
Walid Bakeer   +3 more
core   +1 more source

A review on Acinetobacter baumannii

open access: yesJournal of Acute Disease, 2019
Acinetobacter baumannii is a major cause of nosocomial infections worldwide. By summarizing the epidemiology, molecular and drug resistance mechanisms, diagnosis and treatment strategies of Acinetobacter baumannii, the clinical outcome is finally improved.
Xin Wang, Li-Jie Qin
openaire   +2 more sources

Interpretation of Key Updates in the 36th Edition of Clinical and Laboratory Standards Institute M100 Standard

open access: yesiLABMED, EarlyView.
ABSTRACT The Clinical and Laboratory Standards Institute M100 document serves as a cornerstone standard for clinical microbiology laboratories in China. Maintaining the scientific rigor of its predecessors, the 36th edition incorporates updated epidemiological cutoff values, pharmacokinetic/pharmacodynamic data, and clinical efficacy evidence to revise
Kanghong Xu, Qi Wang, Hui Wang
wiley   +1 more source

Home - About - Disclaimer - Privacy